Analyst Ratings for Allos Therapeutics (ALTH)
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
4/10/2012 | Brean Capital | N/A | Downgrade | Hold (N/A) |
N/A (N/A) |
1.81 (1.84) |
1.66% | Details |
1/23/2012 | JPMorgan | N/A | Downgrade | Neutral (N/A) |
N/A (N/A) |
1.51 (1.84) |
21.85% | Details |